Essential Role of Human T Cell Leukemia Virus Type 1

Animals CD4-Positive T-Lymphocytes / virology Cell Proliferation Disease Models, Animal Disease Transmission, Infectious HTLV-I Infections / pathology Host-Pathogen Interactions Human T-lymphotropic virus 1 / growth & development Mice Mice, Knockout Mice, SCID Viral Regulatory and Accessory Proteins / deficiency
CD4+ CD25+ HTLV-1 humanized mouse models orf-I viral replication

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 05 04 2019
accepted: 11 06 2019
pubmed: 19 7 2019
medline: 3 6 2020
entrez: 19 7 2019
Statut: epublish

Résumé

Human T cell leukemia virus type 1 (HTLV-1) is the ethological agent of adult T cell leukemia/lymphoma (ATLL) and a number of lymphocyte-mediated inflammatory conditions, including HTLV-1-associated myelopathy/tropical spastic paraparesis. HTLV-1

Identifiants

DOI: 10.1128/JVI.00565-19 PMID: 31315992 PMC: PMC6744231
pubmed: 31315992
pii: JVI.00565-19
doi: 10.1128/JVI.00565-19
pmc: PMC6744231
pii:
doi:

Substances chimiques

Viral Regulatory and Accessory Proteins 0
p12I protein, Human T-lymphotropic virus 1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Oncogene. 1999 Aug 5;18(31):4505-14
pubmed: 10442641
J Virol. 2000 Feb;74(3):1094-100
pubmed: 10627519
J Virol. 2000 Nov;74(21):9828-35
pubmed: 11024109
J Virol. 2001 Jul;75(13):6086-94
pubmed: 11390610
Blood. 2001 Aug 1;98(3):823-9
pubmed: 11468184
J Neurovirol. 2001 Jun;7(3):228-34
pubmed: 11517397
Blood. 2002 Jan 1;99(1):88-94
pubmed: 11756157
Cancer Res. 2002 Feb 15;62(4):1083-6
pubmed: 11861386
Blood. 2003 Jul 1;102(1):284-8
pubmed: 12649132
Ann Rheum Dis. 1992 Jun;51(6):769-76
pubmed: 1352097
J Infect Dis. 2004 Aug 1;190(3):504-10
pubmed: 15243924
Retrovirology. 2005 Feb 01;2:4
pubmed: 15686595
Retrovirology. 2005 Mar 02;2:17
pubmed: 15743526
J Infect Dis. 2005 Apr 1;191(7):1140-7
pubmed: 15747250
Blood. 2005 Nov 15;106(10):3380-2
pubmed: 16076875
J Virol. 2006 Nov;80(21):10683-91
pubmed: 16943297
Nat Med. 2006 Nov;12(11):1316-22
pubmed: 17057712
Nat Med. 2008 Apr;14(4):429-36
pubmed: 18376405
Blood. 2009 Apr 16;113(16):3726-34
pubmed: 18791162
J Clin Oncol. 2009 Jan 20;27(3):453-9
pubmed: 19064971
J Virol. 2009 Feb;83(4):2048-54
pubmed: 19073733
Blood. 2010 Apr 1;115(13):2640-8
pubmed: 20124219
Blood. 2010 Aug 26;116(8):1211-9
pubmed: 20448111
Cancer. 2010 Jul 15;116(14):3438-46
pubmed: 20564100
Blood. 2010 Nov 11;116(19):3809-17
pubmed: 20647569
Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20738-43
pubmed: 21076035
PLoS Pathog. 2011 Sep;7(9):e1002231
pubmed: 21909275
Viruses. 2011 Jun;3(6):861-85
pubmed: 21994758
J Virol. 2012 Jan;86(1):339-47
pubmed: 22072769
Best Pract Res Clin Haematol. 2011 Dec;24(4):559-65
pubmed: 22127321
J Forensic Sci. 1990 Sep;35(5):1196-200
pubmed: 2230693
J Med Virol. 2012 Apr;84(4):664-71
pubmed: 22337307
Front Microbiol. 2012 Jul 24;3:270
pubmed: 22837757
Front Microbiol. 2012 Aug 31;3:320
pubmed: 22969759
J Virol. 2014 Jan;88(1):393-402
pubmed: 24155397
Blood. 2014 Jan 16;123(3):346-55
pubmed: 24196073
Immunol Res. 2013 Dec;57(1-3):326-34
pubmed: 24248605
Retrovirology. 2014 Jun 02;11:43
pubmed: 24890041
PLoS Pathog. 2014 Nov 06;10(11):e1004454
pubmed: 25375128
Lancet. 1989 Feb 25;1(8635):441
pubmed: 2563817
Lancet. 1989 Nov 18;2(8673):1184-7
pubmed: 2572904
J Virol. 2015 Oct;89(20):10580-90
pubmed: 26269171
J Virol. 2015 Nov 25;90(5):2195-207
pubmed: 26608313
Genome. 1989;31(2):662-7
pubmed: 2698836
Stem Cells Dev. 2016 Dec 15;25(24):1863-1873
pubmed: 27608727
Annu Rev Pathol. 2017 Jan 24;12:187-215
pubmed: 27959627
J Neuroimmune Pharmacol. 2017 Sep;12(3):504-520
pubmed: 28374110
PLoS Pathog. 2017 Apr 20;13(4):e1006353
pubmed: 28426803
Nat Commun. 2017 May 23;8:15264
pubmed: 28534499
Cancer Res. 1985 Sep;45(9 Suppl):4644s-4645s
pubmed: 2861896
Lancet. 1985 Aug 24;2(8452):407-10
pubmed: 2863442
Nat Commun. 2017 Jun 22;8:15890
pubmed: 28639618
Lancet. 1986 May 3;1(8488):1031-2
pubmed: 2871307
Annu Rev Virol. 2017 Sep 29;4(1):393-412
pubmed: 28746819
Leukemia. 2017 Nov;31(11):2532-2535
pubmed: 28811663
PLoS Pathog. 2018 Mar 22;14(3):e1006933
pubmed: 29566098
Curr Protoc Mouse Biol. 2018 Mar;8(1):17-27
pubmed: 29988984
Blood. 1977 Sep;50(3):481-92
pubmed: 301762
J Virol. 1987 Jul;61(7):2175-81
pubmed: 3035218
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7124-8
pubmed: 3174625
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Science. 1995 Jul 7;269(5220):79-81
pubmed: 7604283
Rinsho Ketsueki. 1995 Jun;36(6):573-7
pubmed: 7643453
Lancet. 1994 Oct 22;344(8930):1116-9
pubmed: 7934493
Blood. 1993 Aug 1;82(3):722-31
pubmed: 8338942
Blood. 1993 Oct 15;82(8):2501-9
pubmed: 8400297
J Virol. 1996 Jun;70(6):3599-605
pubmed: 8648694
Virology. 1997 Oct 13;237(1):123-8
pubmed: 9344914
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13897-902
pubmed: 9391124
Blood. 1998 Jun 15;91(12):4701-7
pubmed: 9616168
Methods. 1998 Sep;16(1):83-94
pubmed: 9774518

Auteurs

Veronica Galli (V)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Christopher C Nixon (CC)

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA.

Natasa Strbo (N)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Maria Artesi (M)

Laboratory of Experimental Hematology, Jules Bordet Institute, Free University of Brussels, Brussels, Belgium.
Unit of Animal Genomics, GIGA, University of Liège, Liège, Belgium.

Maria F de Castro-Amarante (MF)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Katherine McKinnon (K)

Vaccine Branch Flow Cytometry Core, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Dai Fujikawa (D)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Maria Omsland (M)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Robyn Washington-Parks (R)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Laura Romero (L)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Breanna Caruso (B)

Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

Keith Durkin (K)

Laboratory of Experimental Hematology, Jules Bordet Institute, Free University of Brussels, Brussels, Belgium.
Unit of Animal Genomics, GIGA, University of Liège, Liège, Belgium.

Sophia Brown (S)

Vaccine Branch Flow Cytometry Core, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Baktiar Karim (B)

Pathology/Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Monica Vaccari (M)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Steve Jacobson (S)

Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

Jerome A Zack (JA)

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA.

Anne Van den Broeke (A)

Laboratory of Experimental Hematology, Jules Bordet Institute, Free University of Brussels, Brussels, Belgium.
Unit of Animal Genomics, GIGA, University of Liège, Liège, Belgium.

Cynthia Pise-Masison (C)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cynthia.masison@mail.nih.gov franchig@mail.nih.gov.

Genoveffa Franchini (G)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cynthia.masison@mail.nih.gov franchig@mail.nih.gov.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD4+ › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Environnement et santé publique › Santé publique › Transmission de maladie infectieuse › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à deltarétrovirus › Infections à HTLV-I › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Phénomènes biologiques › Interactions hôte-microbes › Interactions hôte-pathogène › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Deltaretrovirus › Virus T-lymphotrope de type 1 des primates › Virus T-lymphotrope humain de type 1 › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souches mutantes de souris › Souris SCID › Essential Role of Human T Cell Leukemia Virus Type 1
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales régulatrices ou accessoires › Essential Role of Human T Cell Leukemia Virus Type 1